The science on the added ingredients: PEA (Palmitoylethanolamide) has been studied in human trials for pain and inflammation
A 2025 systematic review of the musculoskeletal literature found that BPC-157 improved outcomes in muscle, tendon, ligament, and bone injury models, while noting that the evidence comes largely from animal studies [1]
At the same time, TB-500 activates actin polymerization, a cytoskeletal protein, allowing fibroblasts and endothelial cells to migrate extremely rapidly through these newly formed pathways directly to the site of injury
Theyre hot online, that sort of thing
The plasma NAD(+) metabolome is dysregulated in normal aging
Typical research dosing window: 200-500 mcg of the combined blend per dosing event (giving 100-250 mcg of each peptide), 1-2 times per 24h cycle in rodent recovery models